Progentix Orthobiology
Latest round
- Series A
Last raised
- Jan 2008
Total raised
- Undisclosed
Investors
- 1
About Progentix Orthobiology
Progentix Orthobiology BV is engaged in the research and development of orthopedic products, particularly synthetic bone substitutes. The company was acquired by NuVasive, Inc. in January 2009 for USD 15 mn, signaling a strategic pivot towards integrating advanced materials into surgical offerings.Progentix Orthobiology BV focuses on producing innovative synthetic bone substitutes designed to improve healing and recovery in orthopedic surgeries. Their product offerings include advanced biologics tailored for use in various surgical procedures, catering to healthcare providers and institutions globally.Progentix Orthobiology BV generates revenue through the sale of its synthetic bone substitutes to healthcare providers and institutions.In the upcoming years, Progentix Orthobiology BV plans to expand its product line by developing new synthetic bone substitutes aimed at various orthopedic applications. The company will target additional markets in Europe and Asia-Pacific by 2024, leveraging its recent acquisition by NuVasive, Inc. to enhance its development capabilities and market reach.
Who invested in Progentix Orthobiology
1 investor across 1 round
See all investors in Progentix Orthobiology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 22, 2008
Amount
Undisclosed
Investors
Questions about Progentix Orthobiology
Who invested in Progentix Orthobiology?
Progentix Orthobiology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Progentix Orthobiology raised?
Progentix Orthobiology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Progentix Orthobiology last raise money?
Progentix Orthobiology's most recent round on record is a Series A, in Jan 2008.
What does Progentix Orthobiology do?
Progentix Orthobiology BV is engaged in the research and development of orthopedic products, particularly synthetic bone substitutes.
Where is Progentix Orthobiology headquartered?
Progentix Orthobiology is headquartered in Netherlands.
Which VCs invest in companies like Progentix Orthobiology?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Progentix Orthobiology's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Progentix Orthobiology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.